Published in Circulation on June 05, 2006
Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol (2011) 3.74
The incidence, pattern, and prognostic value of left ventricular myocardial scar by late gadolinium enhancement in patients with atrial fibrillation . J Am Coll Cardiol (2013) 2.76
Late gadolinium enhancement among survivors of sudden cardiac arrest. JACC Cardiovasc Imaging (2015) 2.70
Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction. Circulation (2008) 2.61
Detection of myocardial damage in patients with sarcoidosis. Circulation (2009) 2.31
ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol (2010) 2.23
Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults. JAMA (2012) 2.21
Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation. J Am Coll Cardiol (2012) 2.18
ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation (2010) 2.14
Prevalence and Correlates of Myocardial Scar in a US Cohort. JAMA (2015) 2.12
Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with known or suspected coronary artery disease. Circulation (2009) 2.01
Stress cardiac magnetic resonance imaging provides effective cardiac risk reclassification in patients with known or suspected stable coronary artery disease. Circulation (2013) 1.87
Stress myocardial perfusion imaging by CMR provides strong prognostic value to cardiac events regardless of patient's sex. JACC Cardiovasc Imaging (2011) 1.83
T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy. Radiology (2012) 1.83
Etiology of sudden death in the community: results of anatomical, metabolic, and genetic evaluation. Am Heart J (2010) 1.70
Prognostic value of stress cardiac magnetic resonance imaging in patients with known or suspected coronary artery disease: a systematic review and meta-analysis. J Am Coll Cardiol (2013) 1.69
Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions. JACC Cardiovasc Imaging (2013) 1.65
Late gadolinium-enhancement cardiac magnetic resonance identifies postinfarction myocardial fibrosis and the border zone at the near cellular level in ex vivo rat heart. Circ Cardiovasc Imaging (2010) 1.63
Unrecognized non-Q-wave myocardial infarction: prevalence and prognostic significance in patients with suspected coronary disease. PLoS Med (2009) 1.62
European Cardiovascular Magnetic Resonance (EuroCMR) registry--multi national results from 57 centers in 15 countries. J Cardiovasc Magn Reson (2013) 1.60
Sudden cardiac death: epidemiology and risk factors. Nat Rev Cardiol (2010) 1.53
Patterns of late gadolinium enhancement in chronic hemodialysis patients. JACC Cardiovasc Imaging (2008) 1.48
Vasodilator stress perfusion CMR imaging is feasible and prognostic in obese patients. JACC Cardiovasc Imaging (2014) 1.44
Prognostic impact of blood pressure response plus gadolinium enhancement in dilated cardiomyopathy. Heart (2015) 1.40
Stress Perfusion Cardiac Magnetic Resonance Imaging Effectively Risk Stratifies Diabetic Patients With Suspected Myocardial Ischemia. Circ Cardiovasc Imaging (2016) 1.37
Comprehensive assessment of myocardial perfusion defects, regional wall motion, and left ventricular function by using 64-section multidetector CT. Radiology (2008) 1.37
Strong cardiovascular prognostic implication of quantitative left atrial contractile function assessed by cardiac magnetic resonance imaging in patients with chronic hypertension. J Cardiovasc Magn Reson (2011) 1.21
Using magnetic resonance imaging to characterize recent myocardial injury: utility in acute coronary syndrome and other clinical scenarios. Circulation (2008) 1.21
Myocardial structure, function, and scar in patients with type 1 diabetes mellitus. Circulation (2011) 1.20
Rationale and design for the Defibrillators to Reduce Risk by Magnetic Resonance Imaging Evaluation (DETERMINE) trial. J Cardiovasc Electrophysiol (2009) 1.15
Toward cardiovascular MRI at 7 T: clinical needs, technical solutions and research promises. Eur Radiol (2010) 1.12
Combined magnetic resonance coronary artery imaging, myocardial perfusion and late gadolinium enhancement in patients with suspected coronary artery disease. J Cardiovasc Magn Reson (2008) 1.11
Myocardial T1 mapping: techniques and potential applications. Radiographics (2014) 1.09
Prediction of cardiac events in patients with reduced left ventricular ejection fraction with dobutamine cardiovascular magnetic resonance assessment of wall motion score index. J Am Coll Cardiol (2008) 1.09
Use of cardiovascular magnetic resonance imaging in acute coronary syndromes. Circulation (2009) 1.08
PET and MRI in cardiac imaging: from validation studies to integrated applications. Eur J Nucl Med Mol Imaging (2009) 1.00
MRI-based prediction of adverse cardiac remodeling after murine myocardial infarction. Am J Physiol Heart Circ Physiol (2012) 0.99
Left ventricular infarct size, peri-infarct zone, and papillary scar measurements: A comparison of high-resolution 3D and conventional 2D late gadolinium enhancement cardiac MR. J Magn Reson Imaging (2009) 0.98
In vivo MRI characterization of progressive cardiac dysfunction in the mdx mouse model of muscular dystrophy. PLoS One (2012) 0.98
ASCI 2010 appropriateness criteria for cardiac magnetic resonance imaging: a report of the Asian Society of Cardiovascular Imaging cardiac computed tomography and cardiac magnetic resonance imaging guideline working group. Int J Cardiovasc Imaging (2010) 0.98
Cardiovascular magnetic resonance for the clinical cardiologist. Can J Cardiol (2007) 0.97
Real-time cine and myocardial perfusion with treadmill exercise stress cardiovascular magnetic resonance in patients referred for stress SPECT. J Cardiovasc Magn Reson (2010) 0.96
Free-breathing, motion-corrected late gadolinium enhancement is robust and extends risk stratification to vulnerable patients. Circ Cardiovasc Imaging (2013) 0.93
Characterization of patients with acute chest pain using cardiac magnetic resonance imaging. Clin Res Cardiol (2008) 0.92
Rapid and accurate determination of relative infarct size in humans using contrast-enhanced magnetic resonance imaging. Clin Res Cardiol (2009) 0.92
Adverse effect of increased left ventricular wall thickness on five year outcomes of patients with negative dobutamine stress. J Cardiovasc Magn Reson (2009) 0.91
Myocardial fibrosis detected by cardiac CT predicts ventricular fibrillation/ventricular tachycardia events in patients with hypertrophic cardiomyopathy. J Cardiovasc Comput Tomogr (2013) 0.89
MultiContrast Delayed Enhancement (MCODE) improves detection of subendocardial myocardial infarction by late gadolinium enhancement cardiovascular magnetic resonance: a clinical validation study. J Cardiovasc Magn Reson (2012) 0.89
Effectiveness of late gadolinium enhancement to improve outcomes prediction in patients referred for cardiovascular magnetic resonance after echocardiography. J Cardiovasc Magn Reson (2013) 0.89
Cardiac magnetic resonance and computed tomography angiography for clinical imaging of stable coronary artery disease. Diagnostic classification and risk stratification. Front Physiol (2014) 0.89
Ventricular scars and ventricular tachycardia. Trans Am Clin Climatol Assoc (2009) 0.89
Prognostic value of contrast-enhanced cardiac magnetic resonance imaging in patients with newly diagnosed non-ischemic cardiomyopathy: cohort study. PLoS One (2013) 0.89
Post myocardial infarction of the left ventricle: the course ahead seen by cardiac MRI. Cardiovasc Diagn Ther (2012) 0.88
Left ventricular hypertrophy influences cardiac prognosis in patients undergoing dobutamine cardiac stress testing. Circ Cardiovasc Imaging (2010) 0.88
Agreement and disagreement between contrast-enhanced magnetic resonance imaging and nuclear imaging for assessment of myocardial viability. Eur J Nucl Med Mol Imaging (2008) 0.87
Prognosis after ST-elevation myocardial infarction: a study on cardiac magnetic resonance imaging versus clinical routine. Trials (2014) 0.87
Cardiovascular magnetic resonance imaging of myocardial infarction, viability, and cardiomyopathies. Curr Probl Cardiol (2010) 0.87
The cardiac magnetic resonance (CMR) approach to assessing myocardial viability. J Nucl Cardiol (2011) 0.87
Prognostic value of late gadolinium enhancement in hypertensive patients with known or suspected coronary artery disease. Int J Cardiovasc Imaging (2010) 0.86
Myocardial Tissue Characterization: Histological and Pathophysiological Correlation. Curr Cardiovasc Imaging Rep (2014) 0.86
Prevalence and prognosis of myocardial scar in patients with known or suspected coronary artery disease and normal wall motion. J Cardiovasc Magn Reson (2011) 0.86
Non-contrast cardiac computed tomography can accurately detect chronic myocardial infarction: Validation study. J Nucl Cardiol (2010) 0.85
Diagnostic accuracy of stress myocardial perfusion MRI and late gadolinium-enhanced MRI for detecting flow-limiting coronary artery disease: a multicenter study. Eur Radiol (2008) 0.84
Sample Size in Clinical Cardioprotection Trials Using Myocardial Salvage Index, Infarct Size, or Biochemical Markers as Endpoint. J Am Heart Assoc (2016) 0.84
Prognostic value of combined magnetic resonance myocardial perfusion imaging and late gadolinium enhancement. Int J Cardiovasc Imaging (2011) 0.83
Recent advances in the management of chronic stable angina I: approach to the patient, diagnosis, pathophysiology, risk stratification, and gender disparities. Vasc Health Risk Manag (2010) 0.83
Infarct healing is a dynamic process following acute myocardial infarction. J Cardiovasc Magn Reson (2012) 0.83
Cardiovascular magnetic resonance for the assessment of patients undergoing transcatheter aortic valve implantation: a pilot study. J Cardiovasc Magn Reson (2011) 0.83
Established and emerging cardiovascular magnetic resonance techniques for the assessment of stable coronary heart disease and acute coronary syndromes. Quant Imaging Med Surg (2014) 0.83
Computed Tomography and Cardiac Magnetic Resonance in Ischemic Heart Disease. J Am Coll Cardiol (2016) 0.83
Intravenous morphine administration and reperfusion success in ST-elevation myocardial infarction: insights from cardiac magnetic resonance imaging. Clin Res Cardiol (2015) 0.83
Prognostic value of electrocardiographic detection of unrecognized myocardial infarction in persons with stable coronary artery disease: data from the Heart and Soul Study. Clin Res Cardiol (2010) 0.82
Late gadolinium enhancement by cardiovascular magnetic resonance is complementary to left ventricle ejection fraction in predicting prognosis of patients with stable coronary artery disease. J Cardiovasc Magn Reson (2012) 0.82
Are There Deleterious Cardiac Effects of Acute and Chronic Endurance Exercise? Physiol Rev (2016) 0.82
Clinical decision making with myocardial perfusion imaging in patients with known or suspected coronary artery disease. Semin Nucl Med (2014) 0.81
Late gadolinium enhancement as a potential marker of increased perioperative risk in aortic valve replacement. Interact Cardiovasc Thorac Surg (2012) 0.81
Comparison of cardiovascular magnetic resonance of late gadolinium enhancement and diastolic wall thickness to predict recovery of left ventricular function after coronary artery bypass surgery. J Cardiovasc Magn Reson (2008) 0.81
Assessment of myocardial ischemia with cardiovascular magnetic resonance. Prog Cardiovasc Dis (2011) 0.81
Remodeling of the ischemia-reperfused murine heart: 11.7-T cardiac magnetic resonance imaging of contrast-enhanced infarct patches and transmurality. Antioxid Redox Signal (2009) 0.81
Race and Sex Differences in the Incidence and Prognostic Significance of Silent Myocardial Infarction in the Atherosclerosis Risk in Communities (ARIC) Study. Circulation (2016) 0.80
The emerging role of cardiovascular magnetic resonance in the evaluation of Kawasaki disease. Int J Cardiovasc Imaging (2013) 0.80
Effect of Late Gadolinium Enhancement on the Recovery of Left Ventricular Systolic Function After Pulmonary Vein Isolation. J Am Heart Assoc (2016) 0.80
Subclinical Myocardial Disease in Heart Failure Detected by CMR. Curr Cardiovasc Imaging Rep (2014) 0.80
Single-dose gadobutrol in comparison with single-dose gadobenate dimeglumine for magnetic resonance imaging of chronic myocardial infarction at 3 T. Invest Radiol (2014) 0.79
Unifying statistical classification and geodesic active regions for segmentation of cardiac MRI. IEEE Trans Inf Technol Biomed (2008) 0.79
Endogenous assessment of chronic myocardial infarction with T(1ρ)-mapping in patients. J Cardiovasc Magn Reson (2014) 0.79
Postinfarct Left Ventricular Remodelling: A Prevailing Cause of Heart Failure. Cardiol Res Pract (2016) 0.78
Hypertrophic cardiomyopathy in cardiac CT: a validation study on the detection of intramyocardial fibrosis in consecutive patients. Int J Cardiovasc Imaging (2014) 0.78
Mechanisms for overestimating acute myocardial infarct size with gadolinium-enhanced cardiovascular magnetic resonance imaging in humans: a quantitative and kinetic study †. Eur Heart J Cardiovasc Imaging (2015) 0.78
Myocardial perfusion cardiac magnetic resonance for the diagnosis of coronary artery disease: do we need rest images? Int J Cardiovasc Imaging (2009) 0.78
Can cardiac MRI predict outcome in patients at risk for unrecognized myocardial infarction? Nat Clin Pract Cardiovasc Med (2006) 0.78
Incremental prognostic value of the SYNTAX score to late gadolinium-enhanced magnetic resonance images for patients with stable coronary artery disease. Heart Vessels (2015) 0.78
Magnetic resonance imaging in the assessment of ventricular remodeling and viability. Curr Heart Fail Rep (2008) 0.78
Myocardial viability as integral part of the diagnostic and therapeutic approach to ischemic heart failure. J Nucl Cardiol (2015) 0.78
Investigation of cardiomyopathy using cardiac magnetic resonance imaging part 1: Common phenotypes. World J Cardiol (2012) 0.78
Prognostic value of dipyridamole stress cardiac magnetic resonance in patients with known or suspected coronary artery disease: a mid-term follow-up study. Eur Radiol (2015) 0.78
Tissue characterization of the myocardium: state of the art characterization by magnetic resonance and computed tomography imaging. Radiol Clin North Am (2014) 0.77
Cardiac magnetic resonance imaging in heart failure: where the alphabet begins! Heart Fail Rev (2017) 0.77
Heavy metal content of ayurvedic herbal medicine products. JAMA (2004) 7.33
Physicians' decisions to override computerized drug alerts in primary care. Arch Intern Med (2003) 7.01
Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ (2008) 6.97
Trends in use of complementary and alternative medicine by US adults: 1997-2002. Altern Ther Health Med (2005) 6.27
Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet. JAMA (2008) 5.72
Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation (2006) 4.98
Worsening trends in the management and treatment of back pain. JAMA Intern Med (2013) 4.49
Overrides of medication alerts in ambulatory care. Arch Intern Med (2009) 4.24
Racial and ethnic disparities in cancer screening: the importance of foreign birth as a barrier to care. J Gen Intern Med (2003) 3.69
Sham device v inert pill: randomised controlled trial of two placebo treatments. BMJ (2006) 3.31
Characteristics of visits to licensed acupuncturists, chiropractors, massage therapists, and naturopathic physicians. J Am Board Fam Pract (2002) 3.26
Electronic medical record reminders and panel management to improve primary care of elderly patients. Arch Intern Med (2011) 3.22
Hospice use among Medicare managed care and fee-for-service patients dying with cancer. JAMA (2003) 3.19
Linguistic and cultural barriers to care. J Gen Intern Med (2003) 3.15
Should the hemoglobin A1c diagnostic cutoff differ between blacks and whites? A cross-sectional study. Ann Intern Med (2012) 2.75
Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction. Circulation (2008) 2.61
Tai chi exercise in patients with chronic heart failure: a randomized clinical trial. Arch Intern Med (2011) 2.60
Preferences for cardiopulmonary resuscitation among patients 80 years or older: the views of patients and their physicians. J Am Med Dir Assoc (2003) 2.59
Use of complementary and alternative medical therapies among racial and ethnic minority adults: results from the 2002 National Health Interview Survey. J Natl Med Assoc (2005) 2.56
Effects of tai chi mind-body movement therapy on functional status and exercise capacity in patients with chronic heart failure: a randomized controlled trial. Am J Med (2004) 2.50
Patterns and perceptions of care for treatment of back and neck pain: results of a national survey. Spine (Phila Pa 1976) (2003) 2.47
What can hospitalized patients tell us about adverse events? Learning from patient-reported incidents. J Gen Intern Med (2005) 2.46
Differences between early and late readmissions among patients: a cohort study. Ann Intern Med (2015) 2.41
A treatment trial of acupuncture in IBS patients. Am J Gastroenterol (2009) 2.41
Mentoring in medicine: keys to satisfaction. Am J Med (2002) 2.36
Using a multihospital survey to examine the safety culture. Jt Comm J Qual Saf (2004) 2.29
Insurance coverage, medical conditions, and visits to alternative medicine providers: results of a national survey. Arch Intern Med (2002) 2.27
Prevalence and patterns of adult yoga use in the United States: results of a national survey. Altern Ther Health Med (2004) 2.26
A comparison of outcomes resulting from generalist vs specialist care for a single discrete medical condition: a systematic review and methodologic critique. Arch Intern Med (2007) 2.24
External validation of an index to predict up to 9-year mortality of community-dwelling adults aged 65 and older. J Am Geriatr Soc (2011) 2.20
Index to predict 5-year mortality of community-dwelling adults aged 65 and older using data from the National Health Interview Survey. J Gen Intern Med (2009) 2.15
Use of complementary therapies in patients with cardiovascular disease. Am J Cardiol (2006) 2.06
Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with known or suspected coronary artery disease. Circulation (2009) 2.01
An empirical model to estimate the potential impact of medication safety alerts on patient safety, health care utilization, and cost in ambulatory care. Arch Intern Med (2009) 2.01
Screening for statin-related toxicity: the yield of transaminase and creatine kinase measurements in a primary care setting. Arch Intern Med (2003) 1.98
Prediction of 6-month survival of nursing home residents with advanced dementia using ADEPT vs hospice eligibility guidelines. JAMA (2010) 1.87
2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. J Am Coll Cardiol (2009) 1.86
Mentoring matters. Mentoring and career preparation in internal medicine residency training. J Gen Intern Med (2006) 1.83
Addition of choice of complementary therapies to usual care for acute low back pain: a randomized controlled trial. Spine (Phila Pa 1976) (2007) 1.80
Age-specific fluoride exposure in drinking water and osteosarcoma (United States). Cancer Causes Control (2006) 1.76
Complementary and alternative medical therapies for chronic low back pain: What treatments are patients willing to try? BMC Complement Altern Med (2004) 1.76
Length of stay in home care before and after the 1997 Balanced Budget Act. JAMA (2003) 1.72
Satisfaction with quality and access to health care among people with disabling conditions. Int J Qual Health Care (2002) 1.71
Protecting an endangered species: training physicians to conduct clinical research. Acad Med (2009) 1.66
Factors associated with pediatric use of complementary and alternative medicine. Pediatrics (2010) 1.66
n-3 fatty acids and periodontitis in US adults. J Am Diet Assoc (2010) 1.64
Obesity among adults with disabling conditions. JAMA (2002) 1.64
Interventions to improve medication compliance in older patients living in the community: a systematic review of the literature. Drugs Aging (2003) 1.58
Correlates of use of different types of complementary and alternative medicine by breast cancer survivors in the nurses' health study. Breast Cancer Res Treat (2006) 1.57
Participation in research studies: factors associated with failing to meet minority recruitment goals. Ann Epidemiol (2007) 1.56
Patient expectations as predictors of outcome in patients with acute low back pain. J Gen Intern Med (2007) 1.52
Use of mind-body medical therapies. J Gen Intern Med (2004) 1.52
Acupuncture for treatment of persistent arm pain due to repetitive use: a randomized controlled clinical trial. Clin J Pain (2008) 1.51
Perceived benefit of Complementary and Alternative Medicine (CAM) for back pain: a national survey. J Am Board Fam Med (2010) 1.48
Breast cancer screening in women aged 80 and older: results from a national survey. J Am Geriatr Soc (2004) 1.48
Relationship between the prognostic expectations of seriously ill patients undergoing hemodialysis and their nephrologists. JAMA Intern Med (2013) 1.46
Barriers to hospice care among older patients dying with lung and colorectal cancer. J Clin Oncol (2003) 1.46
Quality dimensions that most concern people with physical and sensory disabilities. Arch Intern Med (2003) 1.45
Cost effectiveness of aggressive care for patients with nontraumatic coma. Crit Care Med (2002) 1.45
Comparing the SF-12 and SF-36 health status questionnaires in patients with and without obesity. Health Qual Life Outcomes (2008) 1.45
Health care expenditures associated with overweight and obesity among US adults: importance of age and race. Am J Public Health (2005) 1.45
Use of complementary and alternative medicine among persons with diabetes mellitus: results of a national survey. Am J Public Health (2002) 1.44
Association of hospice agency profit status with patient diagnosis, location of care, and length of stay. JAMA (2011) 1.44
Hospitalization of hospice patients with cancer. J Palliat Med (2003) 1.43
Beyond the comfort zone: residents assess their comfort performing inpatient medical procedures. Am J Med (2006) 1.42
Older Asian Americans and Pacific Islanders dying of cancer use hospice less frequently than older white patients. Am J Med (2003) 1.41
Neuropsychiatric symptoms and expenditure on complementary and alternative medicine. J Clin Psychiatry (2015) 1.41
Outcomes with conversion from calcineurin inhibitors to sirolimus after renal transplantation in the context of steroid withdrawal or steroid continuation. Transplantation (2009) 1.39
Lessons from a patient partnership intervention to prevent adverse drug events. Int J Qual Health Care (2004) 1.39
Obesity and C-reactive protein levels among white, black, and hispanic US adults. Obesity (Silver Spring) (2008) 1.38
Obesity and breast cancer screening. J Gen Intern Med (2004) 1.38
Trends in the ambulatory management of headache: analysis of NAMCS and NHAMCS data 1999-2010. J Gen Intern Med (2015) 1.35
Clinicians' assessments of electronic medication safety alerts in ambulatory care. Arch Intern Med (2009) 1.32
Stage of readiness to control weight and adopt weight control behaviors in primary care. J Gen Intern Med (2005) 1.32
Successful weight loss among obese U.S. adults. Am J Prev Med (2012) 1.31
Prevalence of musculoskeletal pain and statin use. J Gen Intern Med (2008) 1.27
Creation of an innovative inpatient medical procedure service and a method to evaluate house staff competency. J Gen Intern Med (2004) 1.27
Prayer for health concerns: results of a national survey on prevalence and patterns of use. Arch Intern Med (2004) 1.26
The diagnosis and treatment of chronic back pain by acupuncturists, chiropractors, and massage therapists. Clin J Pain (2006) 1.25
Understanding patients' value of weight loss and expectations for bariatric surgery. Obes Surg (2006) 1.22
Strong cardiovascular prognostic implication of quantitative left atrial contractile function assessed by cardiac magnetic resonance imaging in patients with chronic hypertension. J Cardiovasc Magn Reson (2011) 1.21
Yoga for chronic low back pain in a predominantly minority population: a pilot randomized controlled trial. Altern Ther Health Med (2009) 1.21
Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor prognosis late after myocardial infarction. J Am Coll Cardiol (2007) 1.21
Discrepancies between explicit and implicit review: physician and nurse assessments of complications and quality. Health Serv Res (2002) 1.18
The effects of Tai Chi on bone mineral density in postmenopausal women: a systematic review. Arch Phys Med Rehabil (2007) 1.18
T'ai chi and qigong for health: patterns of use in the United States. J Altern Complement Med (2009) 1.17
Use of complementary and alternative therapies by Asian Americans. Results from the National Health Interview Survey. J Gen Intern Med (2007) 1.16
Japanese-style acupuncture for endometriosis-related pelvic pain in adolescents and young women: results of a randomized sham-controlled trial. J Pediatr Adolesc Gynecol (2008) 1.15